Same doctors. Same science. 5x the orders.
Average monthly orders went from $1,836 to $9,320 per practice. Same physicians. Same treatments. Same markets. The only thing added was the marketing.
ZEO makes the product. Physicians use it with patients.
ZEO ScientifiX develops and manufactures regenerative biologic products: stem cell and exosome materials used by physicians to treat pain, orthopedic injury, and wounds. The company operates out of Nova Southeastern University's Collaborative Center for Research in South Florida.
The model is simple. Physician practices buy the product and use it with patients. When a practice orders more, it is because more patients said yes to the treatment.
That makes this an unusually clean test of marketing. Product orders are invoiced. No attribution model, no pixel, no self-reported survey. Just what a practice actually bought, before and after.
They had the science and the supply chain. What they didn't have was demand.
A clinic can carry the best regenerative product in the state. If patients never hear about it, the orders stay flat. Most of these practices were running on referrals, a dated website, and whatever the front desk could explain in ninety seconds.
That is the gap we filled.
Cinematic patient education content, brand films, social media, and paid media. Produced by real filmmakers using AI, at a fraction of what an agency charges and at a speed an agency cannot match.
The structure is what made it scale. We did not sell ZEO a campaign. We built a package any practice in the network could switch on, so the work compounded across 40+ clinics instead of stopping at one.
The strategic fit: we help doctors reach more patients, doctors order more product, ZEO grows.
Regenerative medicine is one of the hardest categories in the country to market. These products are physician-directed rather than FDA-approved, and the rules governing what a clinic may say about them are strict, specific, and unforgiving. Most agencies either do not know those rules or find out the hard way.
ZEO knows precisely what can and cannot be claimed about their biologics. We know how to make a patient care. Every script runs through both. Our team writes it, ZEO's claims standards govern it, and nothing ships that crosses into treatment claims, cure language, guaranteed outcomes, or testimonials that promise a result. The work is built to sit inside FDA and FTC advertising guardrails, not to test them.
The constraint made the work better. When you cannot lean on “this will fix your back,” you have to explain the science, show the physician's expertise, and earn trust honestly. That is harder to write and it converts better, because the patient who books already understands what they are asking for and why.
Average monthly ZEO orders, per practice, before and after.
It held across every specialty
| Specialty | Before | After | Change |
|---|---|---|---|
| Spine and orthopedics | $1,614 | $9,580 | +493% |
| Longevity and aesthetics | $595 | $1,879 | +216% |
| Regenerative and wellness | $6,750 | $13,677 | +103% |
Across the network
Two parties are involved here, so it is worth separating them clearly. The practices paid for the marketing. ZEO received the product orders.
In plain terms: ZEO's network spent $72,200 on marketing and ZEO booked roughly seven dollars of product for every one of those dollars.
A stricter cut, which throws out each practice's sign-up month and stops counting at June 30, gives $407,947 in additional product, or $5.65 per $1. Both figures are real. The only difference is which months are allowed to count.
Steady, profitable, unremarkable. After the package went live, monthly orders climbed to $26,970, with the same physicians, in the same market, treating the same conditions. They now order more product in one month than they used to order in five.
Here is the part worth reading twice. This did not cost ZEO anything. The practices paid for their own marketing. ZEO booked the additional product and spent nothing to get it.
$0 of manufacturer spend.
Your revenue is capped by how many patients your physicians can reach. You can hire more reps and fight harder for freezer space, or you can build demand underneath the accounts you already have.
We build the second one. It shows up in your own order data, it compounds month over month, and it makes your accounts stickier, because you become the reason they grew. Every other growth lever you have costs you money. More reps, more trade shows, deeper discounts, co-op dollars. This one is funded by the accounts themselves.
You are not buying videos. You are buying the reason a patient picks up the phone.
Every practice in this study had the same physicians and the same treatments before and after. What changed is that patients finally understood what was available and why it mattered. The first lift usually landed within 30 days.
ZEO builds the biology. We build the demand. If you make a product that physicians deliver to patients, or you are the practice delivering it, this is repeatable.
Method and disclosures: Figures are drawn from invoiced ZEO ScientifiX product orders. Marketing package sales began January 2026. Before and after figures reflect average monthly orders per practice among practices that added the package and had prior ordering history with ZEO, measured against their own pre-package rate. Primary figures run through July 27, 2026 and count each practice's purchase month onward; the stricter alternative cited counts only full calendar months after the purchase month, through June 30, 2026. Not every practice increased. Practices are identified by specialty and market only. Results vary by practice, market, and specialty. Individual results are not guaranteed. No medical claims are made regarding any product.